Literature DB >> 10609234

Abnormal liver function in workers exposed to low levels of ethylene dichloride and vinyl chloride monomer.

T J Cheng1, M L Huang, N C You, C L Du, T T Chau.   

Abstract

We investigated whether exposure to ethylene dichloride (EDC) and vinyl chloride monomer (VCM) resulted in increased risk of liver damage. Epidemiological information, including occupational, medical, smoking, and drinking history, was obtained by interview from 251 male workers. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) were used as indicators of liver damage. Exposure to moderate or low levels of ECD and VCM resulted in a higher risk of developing abnormal ALT levels than did exposure to lower levels of the chemicals. Results were similar for AST. GGT was not associated with EDC or VCM exposure. Combined exposure to EDC and VCM showed a dose-response relationship in association with abnormal ALT levels. We concluded that relatively low concentrations of VCM and EDC cause liver damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609234     DOI: 10.1097/00043764-199912000-00018

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  3 in total

1.  Evaluation in vinyl chloride monomer-exposed workers and the relationship between liver lesions and gene polymorphisms of metabolic enzymes.

Authors:  Shou-Min Zhu; Xue-Feng Ren; Jun-Xiang Wan; Zhao-Lin Xia
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

2.  Liver function assessment in workers exposed to vinyl chloride.

Authors:  Marco Maroni; Anna Clara Fanetti
Journal:  Int Arch Occup Environ Health       Date:  2005-08-10       Impact factor: 3.015

3.  Synergistic effect of hepatitis virus infection and occupational exposures to vinyl chloride monomer and ethylene dichloride on serum aminotransferase activity.

Authors:  H-I Hsieh; J-D Wang; P-C Chen; T-J Cheng
Journal:  Occup Environ Med       Date:  2003-10       Impact factor: 4.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.